Immune-Onc Therapeutics and Roche Partner to Assess IO-108 for the Treatment of Advanced Hepatocellular Carcinoma #roche #immuneonctherapeutics #io108 #hepatocellularcarcinoma #pharma #collaboration #partnership #agreement #development #pii #safety #efficacy #clinicaltrials #tecentriq #avastin #morpheusliver #program
PharmaShots’ Post
More Relevant Posts
-
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) CEO and managing director Steven Yatomi-Clarke sits down with Jonathan Jackson in the Proactive studio ahead of a presentation of the results of its PTX-100 Phase 1b study at the 15th Annual T-Cell Lymphoma Forum (TCLF) in California from June 6 to 8. The Phase 1b study targeted patients with relapsed and refractory T-cell #lymphomas (r/r TCLs) and successfully met its primary objectives of demonstrating safety and determining pharmacokinetics and pharmacodynamics. Additionally, the study showed a promising preliminary efficacy with a 45% overall response rate, where five out of 11 evaluable patients responded positively to the treatment. Watch at #Proactive #ProactiveInvestors #Biotech #Biopharmaceutcials #Oncology #TCellLymphoma https://lnkd.in/epVKef5J
Prescient Therapeutics PTX-100 shows promising results in Phase 1b study
https://www.youtube.com/
-
Thoughts on this? >> Novartis pauses enrollment for Kisqali breast cancer trials to align with nitrosamine guidelines >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical
Novartis pauses enrollment for Kisqali breast cancer trials to align with new nitrosamine guidelines
https://endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Pfizer, Arvinas’ breast cancer drug combo keeps momentum after Phase 1b update >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharma #biotech #pharmaceutical
Pfizer, Arvinas’ breast cancer drug combo keeps momentum after Phase 1b update
https://endpts.com
-
Thoughts on this? >> Pfizer, Arvinas’ breast cancer drug combo keeps momentum after Phase 1b update >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing
Pfizer, Arvinas’ breast cancer drug combo keeps momentum after Phase 1b update
https://endpts.com
-
Thoughts on this? >> Bristol Myers wins approval for KRAS drug Krazati in colorectal cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical
Bristol Myers wins approval for KRAS drug Krazati in colorectal cancer
https://endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Novartis pauses enrollment for Kisqali breast cancer trials to align with nitrosamine guidelines >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #healthcare #productmarketing #pharmaceutical
Novartis pauses enrollment for Kisqali breast cancer trials to align with new nitrosamine guidelines
https://endpts.com
-
Thoughts on this? >> Nkarta drops a cancer program as autoimmune cell therapy comes into focus >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #productmarketing #healthcare
Nkarta drops a cancer program, putting autoimmune front and center. Will it pay off?
https://endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> IN8bio pauses glioblastoma program, halves workforce as it prioritizes its leukemia asset >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #productmarketing #pharmaceutical
IN8bio pauses glioblastoma program, halves workforce as it prioritizes its leukemia asset
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Imunon shares up over 150% as ovarian cancer treatment extends survival in Phase 2 >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #productmarketing #pharma
Imunon shares up over 150% as ovarian cancer treatment extends survival in Phase 2
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> ALX Oncology continues its CD47 quest, revealing Phase 2 gastric cancer data >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #productmarketing #pharma #healthcare
ALX Oncology continues its CD47 quest, revealing Phase 2 gastric cancer data
endpts.com
